Chronic Kidney Disease

Primary care providers play a critical role in detecting and managing cardiovascular-kidney-metabolic syndrome, according to experts.

Socioeconomic status may play a role in the health outcomes of children and adolescents with chronic kidney disease, according to a published review of current evidence.

Researchers found that adults with overweight or obesity lost more weight with tirzepatide than semaglutide in a head-to-head comparison of the medications using electronic medical records data.

In 2019, former President Donald Trump signed the Advancing American Kidney Health initiative.

A new drug application for sotagliflozin as an adjunct to insulin therapy for adults with type 1 diabetes and chronic kidney disease has been resubmitted to the FDA, according to a press release.

Dietary patterns may vary significantly in patients with different stages of chronic kidney disease, according to an investigation of food group intake among patients in a United Kingdom study.

Combined SGLT2 inhibitor and GLP-1 receptor agonist therapy could provide additional cardiovascular and renal benefits for adults with type 2 diabetes, according to data from a meta-analysis published in The Lancet Diabetes & Endocrinology.

Patients with chronic kidney disease or transplant should have ongoing access to telehealth to help manage care, according to results of a qualitative meta-analysis.

More than one in five adults in the U.S. with type 1 diabetes also have chronic kidney disease, according to findings from a brief report published in Diabetes Care.